MX2013008543A - Sistema de administracion transdermica de farmacos y metodo para usar el mismo. - Google Patents
Sistema de administracion transdermica de farmacos y metodo para usar el mismo.Info
- Publication number
- MX2013008543A MX2013008543A MX2013008543A MX2013008543A MX2013008543A MX 2013008543 A MX2013008543 A MX 2013008543A MX 2013008543 A MX2013008543 A MX 2013008543A MX 2013008543 A MX2013008543 A MX 2013008543A MX 2013008543 A MX2013008543 A MX 2013008543A
- Authority
- MX
- Mexico
- Prior art keywords
- delivery system
- drug delivery
- transdermal drug
- steroid
- adhesive layer
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
- A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
- A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
- A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
- A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
- A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
- A61K9/7061—Polyacrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Dermatology (AREA)
- Ophthalmology & Optometry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Un sistema de administración transdérmica de fármacos que comprende un esteroide como agente activo, en donde el esteroide puede ser propionato de clobetasol, dipropionato de betametasona, amcinonida o etabonato de loteprednol. El sistema de administración transdérmica de fármacos también comprende una capa de adhesivo sensible a la presión y un soporte, en donde el esteroide está presente en la capa de adhesivo sensible a la presión, y en donde la capa de adhesivo sensible a la presión se proporciona en un soporte. El sistema de administración transdérmica de fármacos se puede aplicar sobre el párpado de un paciente en necesidad del mismo, con el fin de tratar una enfermedad del párpado, tal como chalazión, blefaritis o disfunción de las glándulas de Meibomio.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US13/164,037 US8900626B2 (en) | 2011-06-20 | 2011-06-20 | Transdermal drug delivery system and method of using the same |
| PCT/US2012/043126 WO2012177626A1 (en) | 2011-06-20 | 2012-06-19 | Transdermal drug delivery system and method of using the same |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| MX2013008543A true MX2013008543A (es) | 2013-08-12 |
| MX347195B MX347195B (es) | 2017-04-19 |
Family
ID=47353860
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2013008543A MX347195B (es) | 2011-06-20 | 2012-06-19 | Sistema de administración transdérmica de fármacos y método para usar el mismo. |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US8900626B2 (es) |
| EP (1) | EP2720748B1 (es) |
| JP (2) | JP6296977B2 (es) |
| KR (2) | KR102107977B1 (es) |
| CN (1) | CN103429295B (es) |
| CA (1) | CA2831095C (es) |
| ES (1) | ES2627514T3 (es) |
| MX (1) | MX347195B (es) |
| WO (1) | WO2012177626A1 (es) |
Families Citing this family (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP4629578B2 (ja) * | 2003-01-22 | 2011-02-09 | ニチバン株式会社 | 眼疾患治療用経皮吸収型製剤 |
| US8950405B2 (en) * | 2006-05-15 | 2015-02-10 | Tearscience, Inc. | Treatment of obstructive disorders of the eye or eyelid |
| US20080114423A1 (en) | 2006-05-15 | 2008-05-15 | Grenon Stephen M | Apparatus for inner eyelid treatment of meibomian gland dysfunction |
| US7981145B2 (en) | 2005-07-18 | 2011-07-19 | Tearscience Inc. | Treatment of meibomian glands |
| US20090043365A1 (en) | 2005-07-18 | 2009-02-12 | Kolis Scientific, Inc. | Methods, apparatuses, and systems for reducing intraocular pressure as a means of preventing or treating open-angle glaucoma |
| WO2013003594A2 (en) | 2011-06-28 | 2013-01-03 | Tearscience, Inc. | Methods and systems for treating meibomian gland dysfunction using radio-frequency energy |
| US20070060988A1 (en) | 2005-07-18 | 2007-03-15 | Grenon Stephen M | Melting meibomian gland obstructions |
| US8083787B2 (en) * | 2005-07-18 | 2011-12-27 | Tearscience, Inc. | Method and apparatus for treating meibomian gland dysfunction |
| US9314369B2 (en) | 2006-05-15 | 2016-04-19 | Tearscience, Inc. | System for inner eyelid treatment of meibomian gland dysfunction |
| WO2014031857A2 (en) | 2012-08-22 | 2014-02-27 | Tearscience, Inc. | Apparatuses and methods for diagnosing and/or treating lipid transport deficiency in ocular tear films, and related components and devices |
| US9211397B2 (en) * | 2012-12-19 | 2015-12-15 | Senju Usa, Inc. | Patch for treatment of eyelid disease containing clobetasol |
| US9820954B2 (en) | 2015-08-19 | 2017-11-21 | Jenivision Inc. | Quantitative peri-orbital application of ophthalmology drugs |
| US12011388B2 (en) | 2016-03-01 | 2024-06-18 | The Hilsinger Company Parent, Llc | Therapeutic thermal compress with phase-change material |
| US12029681B2 (en) | 2016-03-01 | 2024-07-09 | The Hilsinger Company Parent, Llc | Therapeutic eye mask system |
| WO2018003952A1 (ja) * | 2016-06-29 | 2018-01-04 | センジュ ユーエスエー、インコーポレイテッド | 経皮薬物送達システムおよびその使用方法 |
| USD844795S1 (en) | 2016-11-30 | 2019-04-02 | Bruder Healthcare Company, Llc | Therapeutic eye mask |
| USD871598S1 (en) | 2016-11-30 | 2019-12-31 | Bruder Healthcare Company, Llc | Therapeutic eye mask |
| BR112020008046A2 (pt) * | 2017-11-21 | 2020-10-27 | Axerovision, Inc. | composições e métodos de uso para tratamento de inflamação anormal em glândulas secretoras perioculares ou na superfície ocular |
| US11759472B2 (en) | 2017-11-21 | 2023-09-19 | Cs Pharmaceuticals Limited | Compositions and methods of use for treating aberrant inflammation in peri-ocular secretory glands or at the ocular surface |
| JP7332602B2 (ja) * | 2017-12-28 | 2023-08-23 | センジュ ユーエスエー、インコーポレイテッド | 経皮薬物送達システムおよびその使用方法 |
| EP3758657A4 (en) | 2018-03-02 | 2022-01-19 | The Schepens Eye Research Institute, Inc. | SYSTEM AND METHOD OF TREATMENT OF MEIBOMAN GLAND DYSFUNCTION |
| WO2022010864A1 (en) * | 2020-07-06 | 2022-01-13 | Kindeva Drug Delivery L.P. | Drug delivery device for delivery of clobetasol propionate |
| US20220160668A1 (en) | 2020-11-23 | 2022-05-26 | Sight Sciences, Inc. | Formulations and methods for treating conditions of the eye |
Family Cites Families (29)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1047519A (en) | 1963-06-11 | 1966-11-02 | Glaxo Lab Ltd | 17ª‡,21-diesters of 11,17,21-trihydroxy steroid compounds |
| GB1253831A (en) | 1968-01-19 | 1971-11-17 | Glaxo Lab Ltd | 9alpha,21-DIHALOPREGNANE COMPOUNDS |
| ZA744259B (en) | 1973-08-17 | 1975-06-25 | American Cyanamid Co | Topical steroid |
| US4666441A (en) | 1985-12-17 | 1987-05-19 | Ciba-Geigy Corporation | Multicompartmentalized transdermal patches |
| US4954343A (en) * | 1986-03-29 | 1990-09-04 | Nitto Electric Industrial Co., Ltd. | Dermal pharmaceutical preparations |
| DE3786174T2 (de) | 1987-10-13 | 1993-10-21 | Nicholas S Bodor | Weiche steroide mit anti-entzündungswirkung. |
| ZA966579B (en) * | 1995-08-04 | 1998-02-02 | Wakamoto Pharma Co Ltd | O/W emulsion composition for eye drops. |
| JP2001009985A (ja) * | 1999-07-02 | 2001-01-16 | Hisamitsu Pharmaceut Co Inc | 貼付剤用包装袋及び包装貼付剤 |
| WO2001026648A1 (fr) | 1999-10-13 | 2001-04-19 | Senju Pharmaceutical Co., Ltd. | Preparation d'adhesif a usage ophtalmique pour l'absorption par voie percutanee |
| US20050058695A1 (en) * | 2002-05-30 | 2005-03-17 | Watson Pharmaccuticals, Inc. | Norethindrone sustained release formulations and methods associated therewith |
| JP4629578B2 (ja) | 2003-01-22 | 2011-02-09 | ニチバン株式会社 | 眼疾患治療用経皮吸収型製剤 |
| DK1755616T3 (da) * | 2004-04-08 | 2013-11-25 | Eye Co Pty Ltd | Behandling af ekssudativ retinopati med mineralkortikoider |
| US7754230B2 (en) * | 2004-05-19 | 2010-07-13 | The Regents Of The University Of California | Methods and related compositions for reduction of fat |
| WO2005113002A1 (ja) | 2004-05-21 | 2005-12-01 | Senju Pharmaceutical Co., Ltd. | ムスカリン受容体作動薬を含有する眼科用経皮吸収型製剤 |
| WO2006087968A1 (ja) | 2005-02-17 | 2006-08-24 | Senju Pharmaceutical Co, . Ltd. | 眼科用固形外用薬剤 |
| US20060269475A1 (en) * | 2005-04-11 | 2006-11-30 | Ryu Wonhyoung | Multi-layer structure having a predetermined layer pattern including an agent |
| EP1901708B1 (en) | 2005-07-08 | 2013-09-11 | Senju Pharmaceutical Co., Ltd. | Percutaneously absorptive ophthalmic preparation comprising olopatadine |
| EP1901724A1 (en) | 2005-07-08 | 2008-03-26 | Senju Pharmaceutical Co., Ltd. | Percutaneously absorptive ophthalmic preparation comprising epinastine |
| US20090082381A1 (en) | 2005-07-26 | 2009-03-26 | Akiharu Isowaki | Percutaneously Absorbable Ophthalmic Preparation |
| EP2056809A1 (en) | 2006-08-28 | 2009-05-13 | Senju Pharmaceutical Co., Ltd. | Ophthalmic percutaneous absorption type preparation |
| JP5485135B2 (ja) | 2008-02-27 | 2014-05-07 | 久光製薬株式会社 | 貼付製剤 |
| US20090297590A1 (en) | 2008-05-30 | 2009-12-03 | Masahiro Yamaji | Ketotifen transdermal drug delivery systems and methods for treating ophthalmic disease |
| WO2009154169A1 (ja) * | 2008-06-19 | 2009-12-23 | 学校法人近畿大学 | ペプチド誘導体およびそれを含む涙液分泌促進組成物 |
| US10201548B2 (en) | 2009-03-06 | 2019-02-12 | Sun Pharma Global Fze | Methods for treating ocular inflammatory diseases |
| TW201039815A (en) * | 2009-04-13 | 2010-11-16 | Resolvyx Pharmaceuticals Inc | Compositions and methods for the treatment of inflammation |
| TWI445708B (zh) * | 2009-09-02 | 2014-07-21 | Irm Llc | 作為ｔｌｒ活性調節劑之化合物及組合物 |
| EP3569223A1 (en) | 2009-10-30 | 2019-11-20 | Intratus, Inc. | Methods and compositions for sustained delivery of drugs |
| WO2011120719A1 (de) * | 2010-03-31 | 2011-10-06 | Kiekert Ag | Stellantrieb für ein kraftfahrzeug sowie verriegelungseinrichtung nebst verfahren |
| EP2505618A1 (en) * | 2011-04-01 | 2012-10-03 | Fábrica Nacional De Moneda Y Timbre | Use of electromagnetic wave absorbing markers for the aunthentication of security documents |
-
2011
- 2011-06-20 US US13/164,037 patent/US8900626B2/en not_active Expired - Fee Related
-
2012
- 2012-06-19 JP JP2014517085A patent/JP6296977B2/ja not_active Expired - Fee Related
- 2012-06-19 CA CA2831095A patent/CA2831095C/en not_active Expired - Fee Related
- 2012-06-19 ES ES12802854.5T patent/ES2627514T3/es active Active
- 2012-06-19 WO PCT/US2012/043126 patent/WO2012177626A1/en active Application Filing
- 2012-06-19 EP EP12802854.5A patent/EP2720748B1/en not_active Not-in-force
- 2012-06-19 CN CN201280006627.7A patent/CN103429295B/zh not_active Expired - Fee Related
- 2012-06-19 KR KR1020137025876A patent/KR102107977B1/ko active IP Right Grant
- 2012-06-19 KR KR1020197006444A patent/KR20190026963A/ko not_active Application Discontinuation
- 2012-06-19 MX MX2013008543A patent/MX347195B/es active IP Right Grant
-
2016
- 2016-10-14 JP JP2016202990A patent/JP2017048201A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| EP2720748A1 (en) | 2014-04-23 |
| WO2012177626A1 (en) | 2012-12-27 |
| JP2014519955A (ja) | 2014-08-21 |
| KR20190026963A (ko) | 2019-03-13 |
| EP2720748A4 (en) | 2014-11-26 |
| CN103429295A (zh) | 2013-12-04 |
| CA2831095C (en) | 2015-12-01 |
| ES2627514T3 (es) | 2017-07-28 |
| CN103429295B (zh) | 2017-03-29 |
| CA2831095A1 (en) | 2012-12-27 |
| EP2720748B1 (en) | 2017-05-17 |
| US20120321673A1 (en) | 2012-12-20 |
| JP6296977B2 (ja) | 2018-03-20 |
| JP2017048201A (ja) | 2017-03-09 |
| MX347195B (es) | 2017-04-19 |
| US8900626B2 (en) | 2014-12-02 |
| KR20140019790A (ko) | 2014-02-17 |
| KR102107977B1 (ko) | 2020-05-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX347195B (es) | Sistema de administración transdérmica de fármacos y método para usar el mismo. | |
| JP2014519955A5 (es) | ||
| IN2012DN01225A (es) | ||
| MX2016011841A (es) | Composiciones topicas de corticosteroides. | |
| MY161021A (en) | Controlled release corticosteroid and methods for the treatment of otic disorders | |
| PH12014501351B1 (en) | Fluorinated estrogen receptor modulators and uses thereof | |
| SG194155A1 (en) | Multilayer thin film drug delivery device and methods of making and using the same | |
| BRPI0713257B8 (pt) | sistema terapêutico transdérmico para a aplicação de norelgestromina | |
| ATE496617T1 (de) | Abgabesystem mit gesteuerter freisetzung zur nasalen anwendung von neurotransmittern | |
| SG10201907588XA (en) | Androgen Receptor Modulators And Uses Thereof | |
| UA109785C2 (uk) | Композиція фармацевтичного аерозолю, яка включає аналог вітаміну d і кортикостероїд | |
| MY183873A (en) | Transdermal therapeutic system for application of an agent | |
| MX2022008277A (es) | Composiciones de gel para administracion transdermica para maximizar las concentraciones de farmaco en el estrato corneo y suero, y metodos de uso de las mismas. | |
| PH12014501078A1 (en) | Pharmaceutical compositions and methods of use of 4-pregenen-11�-17-21-triol-3,20-dione derivatives | |
| IN2014DN09817A (es) | ||
| MX2015008021A (es) | Composiciones y metodos para administracion transdermica de hormonas y otros agentes medicos. | |
| MX2016008138A (es) | Sistema para el suministro transdermico de ingredientes activos. | |
| EA201400628A1 (ru) | Трансдермальная терапевтическая система для введения фентанила или его аналога | |
| AU2013330679A8 (en) | Combination drug comprising gemigliptin and metformin, and method for the preparation thereof | |
| BR112022012111A2 (pt) | Sistema terapêutico transdérmico contendo agomelatina | |
| BR112012029697A2 (pt) | polissacarídeo da semente de tamarindo para uso no tratamento de doenças inflamatórias | |
| PH12014501573A1 (en) | Topical pharmaceutical compositions comprising bexarotene and a corticosteroids | |
| WO2009076413A3 (en) | Methods, devices and compositions for controlled drug delivery to injured myocardium | |
| WO2012111996A3 (ko) | 갈란타민 또는 그의 염을 함유하는 경피흡수제제 | |
| MX2015010967A (es) | Formulaciones transdermicas de laquinimod. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Grant or registration |